Caspofungin Labatec 70 mg, Poudre pour solution à diluer pour perfusion
7680684330025
CH-68433
Puder
Associated product:
CASPOFUNGIN Labatec subst sèche 70 mg flac
1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Puder
- Galenic group
- Spray/Puder
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
PRC
|
70.0 MG | Substance | Wirkstoff (Principe actif) |
|
PRC
|
- | Substance | WIZUS |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HNIDK |
|
PRC
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 383.00
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/10/2022
Authorization holder
Labatec Pharma SA
1217 Meyrin
Authorization information
- Swissmedic authorization number
- 68433
- Drug name
- Caspofungin Labatec, Poudre pour solution à diluer pour perfusion
- Galenic form
- PULPI
- ATC Code
- J02AX04
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 16/06/2022
- Authorization expiration date
- 15/06/2027
- IT Number
- 08.06.0.
- Domain
- Human medicine
Package details
- Description (FR)
- CASPOFUNGIN Labatec subst sèche 70 mg flac
- Description (DE)
- CASPOFUNGIN Labatec Trockensub 70 mg Durchstf
- Market launch
- 16/06/2022
- Narcotic (BTM)
- No
Original drug
Cancidas, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung
GTIN: 7680555840011
CHF 475.20
Other package sizes (1)
CASPOFUNGIN Labatec subst sèche 50 mg flac
1 DUR
GTIN: 7680684330018